Potent Inhibition and Global Co-localization Implicate the Transmembrane Kunitz-type Serine Protease Inhibitor Hepatocyte Growth Factor Activator Inhibitor-2 in the Regulation of Epithelial Matriptase Activity

被引:88
|
作者
Szabo, Roman [1 ]
Hobson, John P. [1 ]
List, Karin [1 ]
Molinolo, Alfredo [1 ]
Lin, Chen-Yong [2 ]
Bugge, Thomas H. [1 ]
机构
[1] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA
[2] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1074/jbc.M801970200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocyte growth factor activator inhibitors (HAI)-1 and -2 are recently identified and closely related Kunitz-type transmembrane serine protease inhibitors. Whereas HAI-1 is well established as an inhibitor of the serine proteases matriptase and hepatocyte growth factor activator, the physiological targets of HAI-2 are unknown. Here we show that HAI-2 displays potent inhibitory activity toward matriptase, forms SDS-stable complexes with the serine protease, and blocks matriptase-dependent activation of its candidate physiological substrates pro-prostasin and cell surface-bound pro-urokinase plasminogen activator. To further explore the potential functional relationship between HAI-2 and matriptase, we generated a transgenic mouse strain with a promoterless beta-galactosidase marker gene inserted into the endogenous locus encoding HAI-2 protein and performed a global high resolution mapping of the expression of HAI-2, matriptase, and HAI-1 proteins in all adult tissues. This analysis showed striking co-localization of HAI-2 with matriptase and HAI-1 in epithelial cells of all major organ systems, thus strongly supporting a role of HAI-2 as a physiological regulator of matriptase activity, possibly acting in a redundant or partially redundant manner with HAI-1. Unlike HAI-1 and matriptase, however, HAI-2 expression was also detected in non-epithelial cells of brain and lymph nodes, suggesting that HAI-2 may also be involved in inhibition of serine proteases other than matriptase.
引用
收藏
页码:29495 / 29504
页数:10
相关论文
共 18 条
  • [1] Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor
    Shimomura, T
    Denda, K
    Kitamura, A
    Kawaguchi, T
    Kito, M
    Kondo, J
    Kagaya, S
    Qin, L
    Takata, H
    Miyazawa, K
    Kitamura, N
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) : 6370 - 6376
  • [2] Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor
    Kawaguchi, T
    Qin, L
    Shimomura, T
    Kondo, J
    Matsumoto, K
    Denda, K
    Kitamura, N
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) : 27558 - 27564
  • [3] Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human
    Itoh, H
    Kataoka, H
    Hamasuna, R
    Kitamura, N
    Koono, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 255 (03) : 740 - 748
  • [4] The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells
    Wu, Shang-Ru
    Teng, Chen-Hsin
    Tu, Ya-Ting
    Ko, Chun-Jung
    Cheng, Tai-Shan
    Lan, Shao-Wei
    Lin, Hsin-Ying
    Lin, Hsin-Hsien
    Tu, Hsin-Fang
    Hsiao, Pei-Wen
    Huang, Hsiang-Po
    Chen, Chung-Hsin
    Lee, Ming-Shyue
    SCIENTIFIC REPORTS, 2017, 7
  • [5] The Kunitz domain I of hepatocyte growth factor activator inhibitor-2 is important for suppressing matriptase activity and human prostate cancer cell invasion
    Wu, Shang-Ru
    Huang, Hsiang-Po
    Teng, Chen-Hsin
    Tu, Ya-Ting
    Ko, Chun-Jung
    Lan, Shao-Wei
    Lin, Hsin-Ying
    Lin, Hsin-Hsien
    Tu, Hsin-Fang
    Hsiao, Pei-Wen
    Lee, Ming-Shyue
    CLINICAL & EXPERIMENTAL METASTASIS, 2017, 34 (08) : 508 - 508
  • [6] The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells
    Shang-Ru Wu
    Chen-Hsin Teng
    Ya-Ting Tu
    Chun-Jung Ko
    Tai-Shan Cheng
    Shao-Wei Lan
    Hsin-Ying Lin
    Hsin-Hsien Lin
    Hsin-Fang Tu
    Pei-Wen Hsiao
    Hsiang-Po Huang
    Chung-Hsin Chen
    Ming-Shyue Lee
    Scientific Reports, 7
  • [7] Requirement of the activity of hepatocyte growth factor activator inhibitor type 1 for the extracellular appearance of a transmembrane serine protease matriptase in monkey kidney COS-1 cells
    Yuka Miyake
    Satoshi Tsuzuki
    Makoto Yasumoto
    Tohru Fushiki
    Kuniyo Inouye
    Cytotechnology, 2009, 60 : 95 - 103
  • [8] Requirement of the activity of hepatocyte growth factor activator inhibitor type 1 for the extracellular appearance of a transmembrane serine protease matriptase in monkey kidney COS-1 cells
    Miyake, Yuka
    Tsuzuki, Satoshi
    Yasumoto, Makoto
    Fushiki, Tohru
    Inouye, Kuniyo
    CYTOTECHNOLOGY, 2009, 60 (1-3) : 95 - 103
  • [9] Author Correction: The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells
    Shang-Ru Wu
    Chen-Hsin Teng
    Ya-Ting Tu
    Chun-Jung Ko
    Tai-Shan Cheng
    Shao-Wei Lan
    Hsin-Ying Lin
    Hsin-Hsien Lin
    Hsin-Fang Tu
    Pei-Wen Hsiao
    Hsiang-Po Huang
    Chung-Hsin Chen
    Ming-Shyue Lee
    Scientific Reports, 10
  • [10] TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor
    Hashimoto, Tomio
    Kato, Minoru
    Shimomura, Takeshi
    Kitamura, Naomi
    FEBS JOURNAL, 2010, 277 (23) : 4888 - 4900